northernbook Chapter 334 Global pharmaceutical companies are in a panic.
Chapter 334 Global pharmaceutical companies are in a panic.
……
"The factory price of a new drug might only be $700 a month..."
"After Huaxia Medical Insurance, it only costs less than $300."
"What impact do you think this price will have on us? When the stock market opened today, our share price dropped another 5%. What do you think?"
Mursi looked at the executives,
There was not even a trace of a smile on his face, and he looked extremely serious.
In fact, he really couldn't laugh now. Pfizer's recent situation was indeed very bad.
The stock price has been falling continuously, and today it has lost 5% of its market value at the beginning. That’s all money!
Although the numbers in the stock market are just numbers and a temporary increase is meaningless, if the price fails to recover, the loss will be real money.
The most important thing is that Pfizer has been continuously buying back its own shares to prove the company's confidence to the market, but it still cannot stop the stock price from falling. It falls every day, the only difference is how much it falls, but there is still no trend of rising again. This is the worst case scenario.
Now, Antai Pharmaceutical Group's first anti-cancer drug is about to be launched on the market, and its price is so low that it is frightening.
A cancer drug costs less than $300 a month.
This is something that no pharmaceutical company could imagine, especially since this New Year's drug has no competitors and is also a life-saving drug for patients. This is even more unimaginable for many pharmaceutical companies.
If this new drug were in their hands, the price would be at least ten times higher, possibly even twenty times higher.
However, Antai Pharmaceutical Group decided on such a low drug price, which made many pharmaceutical companies unable to understand and inevitably feel anxious.
"By doing this, Antai Pharmaceutical Group has violated industry rules."
"I think we need to talk to Antai Pharmaceutical Group, and then we can join forces with other pharmaceutical companies to put pressure on them."
An executive offered his opinion.
In her opinion, by doing this, Antai Pharmaceutical Group has violated the rules that all pharmaceutical companies must follow, and they must work together to curb it.
As long as Antai Pharmaceutical Group surrenders, this matter can be resolved.
"Talk? What's the point of talking? Will Antai Pharmaceutical Group talk to you?"
"What's more, this time, Antai Pharmaceutical Group's new drug has not even been launched on the market, but it has already been included in Huaxia's medical insurance. It is obvious that Huaxia is supporting Antai Pharmaceutical Group."
"If we want Antai Pharmaceutical Group to bow down, we must first resist the pressure from the entire Chinese nation. Do you think we can withstand this pressure now?"
Mursi said helplessly.
He even felt that this executive spoke without thinking and said whatever came to his mind.
The whole world can see that China is protecting Antai Pharmaceutical Group. Whoever touches Antai Pharmaceutical Group is China's enemy.
When it comes to fair competition, the Chinese government has nothing to say. However, if someone has any evil intentions, China will certainly not sit idly by and will definitely take drastic action.
Given Pfizer's current situation, if it falls out with Chinese officials again, its stock price will inevitably plummet, which is a loss that Pfizer cannot afford now.
Therefore, this question is meaningless and Antai Pharmaceutical Group will not pay attention to this kind of pressure now.
"Think more about how to release good news."
“Now that the stock price has fallen so much, the board of directors has a lot of opinions.”
"So, the most important thing now is to stabilize the stock price, and it would be best to use some good news to push the stock price up."
Mursi said with an ugly expression.
There is currently no way to deal with Antai Pharmaceutical Group.
He had previously wanted Chen Xuan to come to America to take action, but the latter refused to be fooled and never left China, leaving him with no way out.
"There haven't been any major market changes for the drugs we're dealing with right now."
"If we want to release good news, we can only find ways from outside, such as opening up new markets."
"If we can acquire a new drug that's about to be launched, like Novartis did, perhaps the market will regain confidence in us."
Another more mature executive shared his insights.
Given Pfizer's current situation, it is impossible to rely on drugs that are already on the market.
The markets for these drugs are either already fixed or have begun to decline, leaving little opportunity for new markets to open up.
Therefore, the only option now is to start with new drugs, and Pfizer does not have any new drug projects worth promoting, so it can only make external acquisitions.
"Oh? Do you have any recommendations?"
Mursi immediately became interested.
This executive suddenly made this suggestion, he must have found a suitable candidate.
“Yes, I found a company that is developing a new drug.”
"This new drug is an anti-cancer drug and is currently undergoing phase III clinical trials. The current feedback is very ideal."
"If we can acquire it, perhaps we can solve the current problems, let the market see our future growth potential, and restore the market's confidence in Pfizer."
The executive said immediately.
At the same time, he also directly took out this research report, which contained a very complete market analysis.
When Mursi saw the research report, he immediately became excited. This is indeed a very promising anti-cancer drug.
If it can be successfully developed, its market will not necessarily be smaller than that of liver cancer and lung cancer specific drugs, and it will indeed meet Pfizer's future strategic development.
"Okay, let's do a background check on this company first."
“If it’s suitable, we’ll take it over directly, and then we’ll take over the Phase III clinical trial.”
"The marketing department must also be prepared. Once the acquisition is confirmed, the news must be released as soon as possible to restore market confidence."
Mursi made the decision immediately.
The main reason is that Pfizer is in a very bad situation now and its stock price has been falling.
The board members now have strong opinions, and as chairman and chief operating officer, he must resolve this issue as soon as possible.
Now that he saw a glimmer of hope, how could he not seize it? Of course, he had to implement it as soon as possible.
……
And on the other side,
Inside the office of the chairman of Changfeng Group.
"two thousand?"
"A 60% reimbursement rate?"
"This is too much. It's simply destroying the market. Can he bear such a heavy responsibility?"
Qin Guoming couldn't help but curse.
The medicine cost only 2000 yuan a month, which made him think Chen Xuan was crazy.
By doing so, they are making enemies with all pharmaceutical companies, and no pharmaceutical company can tolerate Antai Pharmaceutical Group.
The reason why he was so anxious was certainly not because he was worried that Antai Pharmaceutical Group would become a public enemy. He was not that kind-hearted.
However, Chen Xuan's low price made him extremely anxious, fearing that he and Changfeng Group would be targeted by the public.
After all, Changfeng Group’s medicines are not cheap at all.
Not to mention that the medicines represented by Changfeng Group are very expensive, even the generic drugs launched by Changfeng Group are very expensive.
Even though the cost of imitation is very low, it does not prevent Changfeng Group from selling it at a very high price. It uses its brand awareness to directly sell it at the highest price.
It’s okay to do this normally, as everyone does it anyway. Changfeng Group can also use drug costs as an excuse, and the public has no way to stop it. No one will know the actual cost.
But it is no longer possible now. With the example of Antai Pharmaceutical Group, there is no way to use the reason of production cost.
After all, Antai Pharmaceutical Group's original drugs can be sold at such a low price, especially this original drug, which is the most powerful anti-cancer drug in the world.
In this case, the medicine can be sold at the lowest possible price.
On the contrary, some of Changfeng Group's generic drugs are sold at such high prices, which is totally unacceptable.
Therefore, after this pricing is made public, Changfeng Group will definitely use it for comparison and be criticized by the public.
The impact is not big, but it is not small either. However, it will definitely leave everyone with an impression that the prices are high, the quality is low, and the premium is too high, which will easily lead to the loss of these consumers.
That's why Qin Guoming is so nervous.
……